The substantial Eye-Services provider Dr Agrwal’s Health Care files DRHP(Draft Red Herring Prospectus) to the SEBI for IPO, the company wants to raise its funds via an IPO, which combines 300 crores of fresh issues and 6.96 crores of OFS. Promoters and other shareholders want to exit from their position by offer for sale.
This share would listed in NSE and BSE. The company will use ₹195 crore from new funding for general business expenses, potential acquisitions, and debt repayments. According to the draft red herring prospectus (DRHP), The offer also includes a subscription for eligible employees.
According to a CRISIL MI&A report, the company held about 25 per cent of the total eye care service chain market in India during FY 2024.
This company’s book-running lead manager’s name is Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, and Motilal Oswal Investment Advisors Limited, and Amar Agrawal is the owner of this health care. It’s noticeable that the company’s debt-to-equity shares improved from 1.3 in FY23 TO 0.70 in FY24. The company’s total liabilities were ₹100.57 crore in 2021 and increased to ₹338.61 crore in 2024.
This company was established in the year 1994 along with the registered company Madras. This service has advanced strategies like well-experienced doctors and innovation. Dr. Agarwal’s Eye Hospitals are in 13 states and 3 Union Territories in India such as Madhya Pradesh, Rajasthan, Punjab, Gujarat, Haryana, as well as Chandigarh, Andaman, and Puducherry, West Bengal, Maharashtra, Tamil Nadu, Karnataka, Kerala, Andhra Pradesh, Telangana, Odisha.
Dr Agarwal’s Health Care IPO Prospectus:
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | To be Updated Soon |
Dr Agarwal’s Health Care Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax |
| 2022 | ₹713.78 | ₹657.02 | ₹43.16 |
| 2023 | ₹1031.49 | ₹947.90 | ₹103.23 |
| 2024 | ₹1376.45 | ₹1235.88 | ₹95.05 |
Dr Agarwal’s Health Care IPO Valuation – FY2024
Dr Agarwal’s Health Care IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹3.14 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 6.21% |
| Net Asset Value (NAV): | ₹50.53 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Apollo Hospitals Enterprise Limited | 62.50 | 113.47 | 12.97% | 481.93 | 19059.20 Cr. |
| Max Healthcare Institute Limited | 10.89 | 98.56 | 12.58% | 86.54 | 6849.00 Cr. |
| Fortis Healthcare Limited | 7.93 | 76.33 | 7.82% | 101.48 | 6892.92 Cr. |
| Global Health Limited | 17.80 | 62.32 | 16.46% | 108.17 | 3275.11 Cr. |
| Narayana Hrudayalaya Limited | 38.86 | 32.04 | 27.37% | 141.98 | 5018.25 Cr. |
| Krishna Institute Of Medical Sciences Limited | 38.75 | 14.13 | 16.96% | 228.47 | 2498.14 Cr. |
| Aster DM Healthcare Limited | 2.60 | 162.10 | 3.63% | 71.62 | 3698.90 Cr. |
| Rainbow Children’s Medicare Limited | 21.38 | 64.46 | 17.24% | 124.03 | 1296.90 Cr. |
Objects of the Issue
- Repayment/prepayment, in part or full, of certain of our borrowings; and
- General corporate purposes and unidentified inorganic acquisition.
IPO Lead Managers aka Merchant Bankers
- Kotak Mahindra Capital Company Limited
- Morgan Stanley India Company Private Limited
- Jefferies India Private Limited
- Motilal Oswal Investment Advisors Limited
